SENEX BIOTECHNOLOGY, INC.

Basic Information

715 Sumter Street
Columbia, SC, 29208-

Company Profile

n/a

Additional Details

Field Value
DUNS: 170943240
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. CDK8/19 inhibitors for therapy of advanced prostate cancer

    Amount: $240,750.00

    DESCRIPTION provided by applicant All existing forms of androgen deprivation therapy ADT the backbone of systemic prostate cancer PCa treatment involve inhibition of either ligand production ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. CDK3-inhibiting anticancer agents

    Amount: $1,548,102.00

    DESCRIPTION (provided by applicant): This Phase II SBIR project is aimed at developing a novel type of drugs, termed SNX9-class compounds, with a unique combination of two anticancer activities. The f ...

    SBIR Phase II 2011 Department of Health and Human Services
  3. CDK3-inhibiting anticancer agents

    Amount: $107,000.00

    DESCRIPTION (provided by applicant): This Phase I SBIR project is aimed at developing a novel type of anticancer drugs, termed SNX9- class compounds. These compounds have a dual activity: (i) inhibiti ...

    SBIR Phase I 2009 Department of Health and Human Services
  4. Small Molecules Inducing BTG1 Transcription

    Amount: $107,001.00

    DESCRIPTION (provided by applicant): BTG1 is a transcription regulatory protein that interacts with different transcription factors and nuclear receptors. BTG1 acts as a tumor suppressor and as a medi ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. Inhibitors of disease-promoting activities of senescence

    Amount: $802,501.00

    DESCRIPTION (provided by applicant): This project is aimed at developing a new class of drugs, which act by inhibiting pathogenic activities of senescent cells. Cell senescence occurring as a result o ...

    SBIR Phase II 2008 Department of Health and Human Services
  6. Inhibitors of disease-promoting activities of senescence

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The proposed project is aimed at developing a novel class of drugs against chronic diseases associated with old age. Such agents act by inhibiting a newly discover ...

    SBIR Phase I 2006 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government